Cargando…

Growing old with HIV — dealing with co-morbidities

Detalles Bibliográficos
Autor principal:	Powderly, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112838/ http://dx.doi.org/10.1186/1758-2652-13-S4-O25

Ejemplares similares

Highlights of the 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, November 2010
por: Schambelan, M
Publicado: (2010)

Scene management approaches in dealing with drowning injuries: a review study
por: Lari Siahkal, Maryam, et al.
Publicado: (2022)

Dealing with anorexia nervosa among children and adolescents within a regional area
por: Hansen, Benjamin, et al.
Publicado: (2015)

OA11 Treatment challenges and co-morbidity issues in a patient with Arthritis Mutilans
por: Loh, Chooi Shawn, et al.
Publicado: (2022)

How to deal with a clustering effect in the assessment of a hand hygiene improvement strategy implemented worldwide?
por: Gayet-Ageron, A, et al.
Publicado: (2011)

S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis
por: Mbangiwa, Tshepiso, et al.
Publicado: (2022)

The assessment of management morbidity in children with myelomeningocoele
por: Gan, YC, et al.
Publicado: (2006)

Is the screening able to lower morbidity in the territory?
por: Gabriele, Aulisa Angelo, et al.
Publicado: (2013)

The growing controversy about growth charts: WHO or regional?
por: Khadilkar, Vaman
Publicado: (2013)

Magnetically controlled growing rod in early onset scoliosis
por: Giacomini, Stefano, et al.
Publicado: (2015)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Growing rod analysis for the fusionless correction of Early Onset Scoliosis (EOS)
por: Quick, Mark E, et al.
Publicado: (2015)

Growing spinal systems and early onset deformities: is hyperkhyphosis a contraindication?
por: Giacomini, Stefano, et al.
Publicado: (2015)

P385 Candida auris: a growing threat to global health
por: Varma, Sharin, et al.
Publicado: (2022)

O052 Association of co-morbid insomnia and sleep apnoea (COMISA) symptoms with all-cause mortality: Analysis of the NHANES 2005-2008 data
por: Sweetman, A, et al.
Publicado: (2022)

Morbidity associated with hepatitis E virus infection in endemic setting
por: Favorov, Michael, et al.
Publicado: (2010)

Know and grow: a qualitative evaluation of a parent skills training intervention
por: Goodier, Gabrielle, et al.
Publicado: (2014)

Flexible growing rods: polymer rods provide stability to skeletally immature spines
por: Bylski-Austrow, Donita I, et al.
Publicado: (2015)

Role of HIV co-receptor usage in viral pathogenesis and cure
por: Nijhus, Monique
Publicado: (2013)

Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
por: Sunder, Sharada Ramaseri, et al.
Publicado: (2012)

Modeling the effects of vector control interventions in reducing malaria transmission, morbidity and mortality
por: Chitnis, Nakul, et al.
Publicado: (2010)

Screening of differentially expressed gene in HIV/HCV co-infected patients
por: Yang, zhengrong, et al.
Publicado: (2010)

Chikungunya infection: six years after, rheumatic morbidity and impaired quality of life persist!
por: Simon, F, et al.
Publicado: (2014)

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
por: Metcalfe, John, et al.
Publicado: (2010)

5612627 MORTALITY, CHRONIC MORBIDITY AND INTENSITY OF TREATMENTS IN A NATURAL HISTORY COHORT OF SICKLE CELL DISEASE
por: Reggiani, G., et al.
Publicado: (2023)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
por: Huik, Kristi, et al.
Publicado: (2014)

P17-05. Dealing with HIV-1 diversity
por: Rosario, M, et al.
Publicado: (2009)

Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)

S117: LONG-TERM FOLLOW UP OF DUTCH PATIENTS WITH SCD DIAGNOSED BY NEONATAL SCREENING -- EFFECT ON THE MORBIDITY AND MORTALITY IN THE NETHERLANDS.
por: Vuong, C, et al.
Publicado: (2022)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
por: Wheatley, AK, et al.
Publicado: (2009)

Morbidity, mortality and mid-term follow-up in patients developing renal insufficiency after on-pump and off-pump coronary surgery
por: Ergunes, K, et al.
Publicado: (2013)

Attacking latent HIV: towards eradication of HIV infection
por: Margolis, DM
Publicado: (2006)

Factors affecting cardiovascular morbidity in young FMF patients. A comparative analysis in colchicine treated FMF patients with and without cardiovascular disease
por: Roitman, AJ, et al.
Publicado: (2015)

Consensual vs. coercive treatment: new manifestations of an old dilemma
por: Appelbaum, Paul
Publicado: (2007)

Cyclic CMP and cyclic UMP: new (old) second messengers
por: Seifert, Roland, et al.
Publicado: (2011)

Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
por: Powderly, John, et al.
Publicado: (2015)

Innate immune sensing of a growing tumor in vivo occurs via the host sting pathway and involves mitochondrial DNA transfer from cancer cells to DCs
por: Woo, Seng-Ryong, et al.
Publicado: (2013)

Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f2jq107l73vp0akjrq6da2o5ek